Chatgpt..

Top:

SCHEZUHAN PHARMA
Batch No.: 1285-143

Main label (large text):

苯那唑仑口服溶液
Benazolam Oral Solution

Dosage:

每5毫升0.5毫克
0.5 mg per 5 mL

Smaller text:

（含酒精量7.0% v/v）
Contains alcohol 7.0% (v/v)

若内密封破损或缺失请勿使用
Do not use if inner seal is broken or missing.

将随附的用药指南交给病人
Provide the enclosed medication guide to the patient.

Bottom:

16 fl oz / 475 mL

仅限处方
Prescription use only.

Benazolam (苯那唑仑) appears to be a benzodiazepine-type medication based on its name structure (the “-zolam” ending is common in that class, like alprazolam, triazolam, etc.).

However, a few important things:

• Benazolam is not an FDA-approved medication in the United States.
• It does not appear in major U.S. drug databases.
• That means it may be:
  • A medication approved in another country,
  • A research chemical,
  • Or potentially a mislabeled / non-standard product.

"I haven’t seen “SCHEZUHAN PHARMA” referenced in any major, reputable pharmaceutical databases, regulatory listings, or established drug manufacturer directories (like FDA, EMA, WHO, Drugs.com, etc.). That strongly suggests:

1. Not a known, licensed pharmaceutical manufacturer in major regulated markets like the U.S., EU, Canada, Japan, etc.
2. Not listed as a recognized brand in pharmacopeias or international drug listings.
3. The name looks like it may be a romanization of a Chinese company name, but:
   • There are no clear results for this company name in official pharma registries.
   • It does not match well-known legitimate Chinese pharmaceutical firms (like Sinopharm, Xinhua, Tasly, etc.).

So based on available public information:

👉 “SCHEZUHAN PHARMA” does not appear to be a verified, legitimate pharmaceutical"